Chinese Biotech Firm Rundo International Raises Nearly $15M In Series C Round

Login to View

Chinese biotechnology firm Rundo International has raised RMB100 million (US$14.85 million) in a series C round of financing from the country’s private equity firm Riverhead Capital, according to a statement released by the company on Monday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in